Title : Update on International Medical Taxonomies of Biomarkers and Their Applications in Management of Thyroid Cancers.

Pub. Date : 2022 Mar 9

PMID : 35328215






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Noteworthy are BRAF and RET/PTC alterations already validated as targets of Dabrafenib-mesylate, Pralsetinib and Selpercatinib. Dabrafenib mesylate ret proto-oncogene Homo sapiens
2 Noteworthy are BRAF and RET/PTC alterations already validated as targets of Dabrafenib-mesylate, Pralsetinib and Selpercatinib. Dabrafenib mesylate ret proto-oncogene Homo sapiens